BRIEF published on 11/03/2025 at 10:02, 4 months 23 days ago Thomas Meier Appointed CEO of Medios AG Growth Strategy CEO Appointment Medios AG Specialty Pharma Thomas Meier
PRESS RELEASE published on 11/03/2025 at 09:57, 4 months 23 days ago Thomas Meier becomes new CEO of Medios AG Thomas Meier appointed as new CEO of Medios AG effective February 1, 2026, succeeding Matthias Gaertner. Meier's past roles include CEO of Bachem Holding AG. Medios AG aims for further growth under his leadership CEO Appointment Medios AG Specialty Pharma Thomas Meier Bachem Holding AG
BRIEF published on 10/24/2025 at 11:09, 5 months 2 days ago Medios AG: Reallocation of Bencis Shares Medios AG Specialty Pharma Share Reallocation Bencis Capital Partners Janus Henderson Group
PRESS RELEASE published on 10/24/2025 at 11:04, 5 months 2 days ago Medios AG: Reallocation of Bencis shares Medios AG announces reallocation of Bencis shares to Janus Henderson, representing approximately 6.7% of share capital. Bencis sold shares acquired in 2024 through capital increase related to Ceban Pharmaceuticals B.V Janus Henderson Medios AG Specialty Pharma Bencis Shares Individualized Medicine
BRIEF published on 08/13/2025 at 07:42, 7 months 13 days ago Medios AG Reports Strong Growth in H1 2025 Revenue Growth Medios AG EBITDA Increase H1 2025 Pharmaceutical Segments
PRESS RELEASE published on 08/13/2025 at 07:37, 7 months 13 days ago Medios accelerates growth in the first half of 2025 and significantly increases earnings Medios accelerates growth in the first half of 2025, with revenue up by 9.3% to €991.7 million and EBITDA significantly increasing by 48.8%. Successful share buyback. Positive outlook for 2025 EBITDA Revenue Outlook Growth Medios
BRIEF published on 07/11/2025 at 10:00, 8 months 15 days ago Medios Completes Share Buyback Offer Share Buyback Investor Relations Medios AG Public Offer Capital Acquisition
PRESS RELEASE published on 07/11/2025 at 09:55, 8 months 15 days ago Medios successfully completes public share buyback offer Medios AG successfully completes public share buyback offer, acquiring 3.92% of its share capital. Important dates for Medios Group in 2025 included Share Buyback Financial Report Medios AG Public Offer Specialty Pharma
BRIEF published on 06/18/2025 at 19:21, 9 months 7 days ago Medios Announces Public Share Buyback Offer Share Buyback Stock Exchange Medios AG Capital Market Investment Offer
PRESS RELEASE published on 06/18/2025 at 19:16, 9 months 7 days ago EQS-Adhoc: Medios adopts public share buyback offer for up to 1 million shares at a price of EUR 12.50 Medios AG adopts public share buyback offer for up to 1 million shares at a price of EUR 12.50, providing a premium to shareholders Share Buyback Medios AG Public Offer Premium EUR 12.50
Published on 03/26/2026 at 12:45, 12 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 12 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 12:30, 27 minutes ago Nextech3D.ai Expands Blockchain Ticketing Payments to Apple Pay and Google Pay, Advancing Platform Readiness for Adoption
Published on 03/26/2026 at 12:05, 52 minutes ago Aton Reports the First Results from its Abu Marawat RC Infill Drill Programme, Including 17.13 g/t Gold, 307 g/t Silver, 0.82% Copper and 5.50% Zinc Over a 9 Metre Interval
Published on 03/26/2026 at 12:45, 11 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 36 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 12:17, 39 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 03/26/2026 at 12:05, 51 minutes ago Artlist Expands Its AI Platform with Professional-Grade AI Music for Video Production
Published on 03/26/2026 at 11:56, 1 hour ago IVU continues its growth trajectory in the 2025 financial year
Published on 03/26/2026 at 07:30, 5 hours 27 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 18 hours 26 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 19 hours 12 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
